Literature DB >> 8144042

A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein.

N Hori1, K S Chae, K Murakawa, R Matoba, A Fukushima, K Okubo, K Matsubara.   

Abstract

Sequencing of about 1000 3'-directed cDNA clones from the human HepG2 cell line revealed that about half of them represent transcripts of abundantly or moderately expressed genes, about 70% of which are novel. We identified one of these clones as encoding the human homologue of bovine phosphatidylethanolamine-binding protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8144042     DOI: 10.1016/0378-1119(94)90562-2

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  6 in total

1.  Role of Raf Kinase Inhibitor Protein in Pathophysiology of Prostate Cancer.

Authors:  Evan T Keller
Journal:  For Immunopathol Dis Therap       Date:  2011

2.  Loss of RKIP expression is associated with poor survival in GISTs.

Authors:  Olga Martinho; António Gouveia; Paula Silva; Amadeu Pimenta; Rui Manuel Reis; José Manuel Lopes
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

Review 3.  The Role of RKIP in the Regulation of EMT in the Tumor Microenvironment.

Authors:  Hannah Cessna; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

4.  Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.

Authors:  Yang Wang; Juan-Juan Chen; Xiao-Fei Wang; Qiang Wang
Journal:  World J Gastroenterol       Date:  2018-06-21       Impact factor: 5.742

Review 5.  Insights of RKIP-Derived Suppression of Prostate Cancer.

Authors:  Ying Dong; Xiaozeng Lin; Anil Kapoor; Yan Gu; Hui Xu; Pierre Major; Damu Tang
Journal:  Cancers (Basel)       Date:  2021-12-20       Impact factor: 6.639

Review 6.  RKIP Pleiotropic Activities in Cancer and Inflammatory Diseases: Role in Immunity.

Authors:  Roni Touboul; Stavroula Baritaki; Apostolos Zaravinos; Benjamin Bonavida
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.